Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
复制标题
DOI:
10.1158/0008-5472.can-08-4287
复制
发表时间:
2009-06-15
期刊:
影响因子:
11.2
通讯作者:
Muller WJ
中科院分区:
文献类型:
--
作者:
Dillon RL;Marcotte R;Hennessy BT;Woodgett JR;Mills GB;Muller WJ
The PI3K/Akt survival pathway is often dysregulated in cancer. Our previous studies have demonstrated that coexpression of activated Akt1 with activated ErbB2 or polyoma virus middle T antigen uncoupled from the PI3K pathway (PyVmT Y315/322F) accelerates mammary tumor development but cannot rescue the metastatic phenotype associated with these models. Here we report the generation of transgenic mice expressing activated Akt2 in the mammary epithelium. Like the MMTV-Akt1 strain, mammary-specific expression of Akt2 delayed mammary gland involution. However, in contrast to Akt1, coexpression of Akt2 with activated ErbB2 or PyVmT Y315/322F in the mammary glands of transgenic mice did not impact the latency of tumor development. Strikingly Akt2 coexpresssion markedly increased the incidence of pulmonary metastases in both tumor models demonstrating a unique role in tumor progression. Together these observations argue that these highly conserved kinases have distinct biological and biochemical outputs that play opposing roles in mammary tumor induction and metastasis.